- Home
- CVAC vs PARR Comparison
CVAC vs PARR Comparison
Compare CVAC & PARR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CVAC
- PARR
- Stock Information
- Founded
- CVAC 2000
- PARR 1984
- Country
- CVAC Germany
- PARR United States
- Employees
- CVAC N/A
- PARR N/A
- Industry
- CVAC Biotechnology: Pharmaceutical Preparations
- PARR Integrated oil Companies
- Sector
- CVAC Health Care
- PARR Energy
- Exchange
- CVAC Nasdaq
- PARR Nasdaq
- Market Cap
- CVAC 818.8M
- PARR 664.7M
- IPO Year
- CVAC 2020
- PARR N/A
- Fundamental
- Price
- CVAC $3.12
- PARR $13.17
- Analyst Decision
- CVAC Buy
- PARR Buy
- Analyst Count
- CVAC 2
- PARR 7
- Target Price
- CVAC $10.00
- PARR $22.96
- AVG Volume (30 Days)
- CVAC 717.4K
- PARR 1.7M
- Earning Date
- CVAC 04-10-2025
- PARR 05-06-2025
- Dividend Yield
- CVAC N/A
- PARR N/A
- EPS Growth
- CVAC N/A
- PARR N/A
- EPS
- CVAC 0.75
- PARR N/A
- Revenue
- CVAC $554,073,921.00
- PARR $7,974,457,000.00
- Revenue This Year
- CVAC N/A
- PARR N/A
- Revenue Next Year
- CVAC $66.34
- PARR N/A
- P/E Ratio
- CVAC $4.19
- PARR N/A
- Revenue Growth
- CVAC 895.54
- PARR N/A
- 52 Week Low
- CVAC $2.22
- PARR $11.86
- 52 Week High
- CVAC $5.28
- PARR $33.26
- Technical
- Relative Strength Index (RSI)
- CVAC 53.48
- PARR 45.96
- Support Level
- CVAC $3.05
- PARR $12.17
- Resistance Level
- CVAC $3.02
- PARR $14.20
- Average True Range (ATR)
- CVAC 0.19
- PARR 1.04
- MACD
- CVAC 0.06
- PARR -0.08
- Stochastic Oscillator
- CVAC 79.14
- PARR 36.22
About CVAC CureVac N.V.
CureVac is a biopharmaceutical company headquartered in Germany that is developing vaccines and therapies using messenger ribonucleic acid, or mRNA. The company was founded in 2000 and had its initial public offering in August 2020. CureVac had a collaboration with GSK to develop second-generation seasonal influenza and Covid vaccines and an avian influenza vaccine. The company's other pipeline candidates include mRNA vaccines for oncology and molecular therapies spanning tumors, liver, and ocular diseases.
About PARR Par Pacific Holdings Inc.
Par Pacific Holdings Inc is an oil and gas company that manages and maintains interests in energy and infrastructure businesses. The company has three reportable segments namely Refining, Under its refining business, the company produces ultra-low-sulfur diesel, gasoline, jet fuel, marine fuel, LSFO, and other associated refined products. Its Retail includes operation licenses out brands to serve the retail consumer. Through the Logistics segment, crude shipments are delivered to the refineries, in addition to finished products that are exported. It generates maximum revenue from the Refining segment.